Arthur S Kirsch sold $1.7M of Liquidia (LQDA)

Executed Jun 1, disclosed Jun 3, 2 days later.

Value, as filed

$1.7M

30,000 sh across 3 lots

Executed

Jun 1

the trade date, as filed

Disclosed

Jun 3

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Arthur S Kirsch Director profile →

Arthur S Kirsch (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Evommune, Inc. (EVMN). Across 1 priced purchase filing, the average 21-session return was +5.0% from execution and -1.1% from disclosure (delay-adjusted; derived). The largest single filing was $1.7M of LQDA (30,000 sh across 3 lots, as filed), executed Jun 1.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→